Rising prevalence rate of Cervical Cancer, High Incidence rate of HPV infection, Increasing number of Awareness Programs, and Government Initiatives and Funding to Drive Growth of the Microscopy Market
Developing markets such as Middle East, Brazil, Argentina, Mexico, China, India, and Malaysia are lucrative markets for global cervical cancer screening, owing to favorable government incentives and corporate funding.
The report segments the global Cervical cancer screening market by test type,end user, and geography.Based on type oftest, the global cervical cancer screening market is segmented into PAP test, and HPV test/co-testing. PAP test is largest segment in this market. However,HPV/co-test will be the fastest-growing product segment during the forecast period.
Growth in aging female population and rising prevalence rate of cervical cancer, high incidence rate of HPV infection, increasing number of awareness programs cervical cancer screening, and government initiatives and funding are propelling the growth of these segments. Laboratories segment is the major end users of the global cervical cancer screening market in 2014.
New and innovative product launches, acquisition and strategic alliances was found to be a dominant strategy adopted by key industry participants to increase their market share and cater to the unmet market needs.
From an insight perspective, this research report focuses on the qualitative data, market size, and growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats). The report also offers market sizes and related growth of various segments in the industry. It also focuses on the emerging and high-growth segments of the global cervical cancer screening market, high-growth regions, and the initiatives of respective governments.The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on the key players in the global cervical cancer screening market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help the key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.
Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=326185 .
Table of Contents
11 Company Profiles
11.2 Hologic, Inc.
11.3 Qiagen N.V.
11.4 Roche Diagnostics
11.5 Quest Diagnostics
11.6 Oncohealth Corporation
11.7 Femasys, Inc.
Single User License is US $4650 for Discount Inquire@http://www.rnrmarketresearch.com/contacts/discount?rname=326185 .
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.